Combining over 25 years of clinical and operational experience with the most recent scholarship in delivery science, Ginger Biesbrock serves as executive vice president of care transformation at MedAxiom. Her objective is to combine proven organizational performance improvement techniques with an innovation overlay – optimizing the present state while continuously looking to author original solutions.
Beginning her journey as a provider at the patient bedside and evolving through operational leadership in sophisticated organizations, her focus has sharpened. Patient centricity, team-based care, efficient resource utilization, fiscal responsibility and servant leadership are signatures of her work with organizations, large and small, across the U.S.
Prior to MedAxiom, Ginger served as chief operating officer of The Cardiovascular Group at Centra-Health (22 physicians and 10 APPs) in Lynchburg, VA, followed by directing operations at West Michigan Heart (39 physicians and 24 APPs) in Grand Rapids, MI. She has extensive experience in both inpatient and ambulatory settings.
Ginger’s academic work includes a Master of Physician Assistant Studies from Grand Valley State University and a Master of Public Health degree from Michigan State University. She is currently a student in the prestigious Doctoral program for Healthcare Leadership at the University of Alabama – Birmingham with graduation planned for 2022.
Ginger’s experience informs her work and includes contemporary cardiovascular (CV) workforce deployment strategies, CV service line design and leadership structures, CV clinic strategy development, and care team development and optimization. Her work also includes development and authorship of a practical educational curriculum for APPs being introduced to CV medicine, a separate CME offering for those looking for a deeper exposure to the field, and authorship of a nationally recognized survey of APP utilization.
Thursday, January 28, 2021 | Ginger Biesbrock | 0 Comments
Thursday, May 28, 2020 | Ginger Biesbrock | 0 Comments
Thursday, February 27, 2020 | Ginger Biesbrock | 0 Comments